Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Aptadel Therapeutics logo — Aptadel Therapeutics is a biotech company focused on the dev...

Aptadel Therapeutics

Aptadel Therapeutics is a biotech company focused on the development of cancer treatment based on aptamer technology.

Founded 2020 Spain Spain 7 employees Seed Total: $1.70M Biotechnology, Health Care

General Information

Company Name Aptadel Therapeutics
Founded Year 2020
Location Spain Spain +1
Founders / Decision Makers
Team member
Employees 7
Industries Biotechnology, Health Care
Funding Stage Seed
Social

Get notified when Aptadel Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Aptadel Therapeutics

Aptadel Therapeutics is a preclinical-stage biotech company based in Barcelona, Spain with a strong focus on developing cancer treatments utilizing aptamer technology. The company's lead indication is Ewing Sarcoma, a rare form of bone cancer primarily affecting children. Established in 2020, Aptadel Therapeutics recently received a €1.70M investment in a Seed Round, with Alba Pérez Foundation being the lead investor, marking a significant milestone. This biotech startup operates in the Biotechnology and Health Care industries with a goal to revolutionize cancer treatment through its RNA-based delivery platform. With its innovative approach and dedicated team, Aptadel Therapeutics stands at the forefront of the biotech sector, aiming to make a positive impact on cancer therapy.

Taxonomy: Biotech company, Cancer treatment, Aptamer technology, RNA-based delivery platform, Preclinical-stage, Barcelona, Spain, Ewing Sarcoma, Rare cancer, Children's cancer, Biomedical company, Targeted therapy, Preclinical research, RNA-based platform, Aptadel Therapeutics

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
21 Jan 2021

Aptadel Therapeutics Alternatives & Competitors

Aptadel Therapeutics vs
Altamira Therapeutics
Altamira Therapeutics Bermuda

Altamira Therapeutics is dedicated to developing RNA-based therapeutics for extrahepatic targets.

Post Ipo Debt
13 employees
Health Care, Health and Wellness
Aptadel Therapeutics vs
OncXerna Therapeutics
OncXerna Therapeutics United States

Advancing a new paradigm of precision oncology with a RNA-based approach to match patients to novel,...

Series Unknown
8 employees
Biopharma, Biotechnology
Aptadel Therapeutics vs
TransCode Therapeutics, Inc.
TransCode Therapeutics, Inc. United States

Delivering a cancer-free future

Post Ipo Equity
11 employees
Biotechnology, Health Care

FAQ About Aptadel Therapeutics

Aptadel Therapeutics is a biotech company focused on the development of cancer treatment based on aptamer technology.
Aptadel Therapeutics was founded in 2020.
Aptadel Therapeutics is headquartered in Spain.
Aptadel Therapeutics operates in the following industries: Biotechnology, Health Care.
Aptadel Therapeutics has approximately 7 employees.
Aptadel Therapeutics has completed 1 funding round, raising a total of $1.70M. The latest funding stage is Seed.
Top alternatives and competitors to Aptadel Therapeutics include Altamira Therapeutics, OncXerna Therapeutics , TransCode Therapeutics, Inc., TORL BioTherapeutics LLC, RNA GUARDIAN LTD. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Aptadel Therapeutics and Altamira Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Aptadel Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy